Swiss Pharmacan's Supplement Authorized for Immediate Clinical Study to Confirm Effectiveness Against Long-COVID |
| December 21, 2021 | December 2021 Bond Updates |
|
FRAUENFELD, Switzerland, Dec. 21, 2021 /PRNewswire/ -- "The use of ArtemiC Support has shown clear improvement of [long-COVID] symptoms after just a few days," states research collaborator Dr. Francisco Mera Cordero from the Catalan Health Authority DAP Costa de Ponent. COVID-19 is mainly... |
| View more at: https://www.prnewswire.com:443/news-releases/swiss-pharmacans-supplement-authorized-for-immediate-clinical-study-to-confirm-effectiveness-against-long-covid-301448807.html |
| Related News |
|